Osteoporosis International

, Volume 27, Issue 7, pp 2271–2279 | Cite as

The effect of two doses of dried plum on bone density and bone biomarkers in osteopenic postmenopausal women: a randomized, controlled trial

  • S. HooshmandEmail author
  • M. Kern
  • D. Metti
  • P. Shamloufard
  • S. C. Chai
  • S. A. Johnson
  • M. E. Payton
  • B. H. Arjmandi
Original Article



Daily consumption of 50 g of dried plum (equivalent to 5–6 dried plums) for 6 months may be as effective as 100 g of dried plum in preventing bone loss in older, osteopenic postmenopausal women. To some extent, these results may be attributed to the inhibition of bone resorption with the concurrent maintenance of bone formation.


The objective of our current study was to examine the possible dose-dependent effects of dried plum in preventing bone loss in older osteopenic postmenopausal women.


Forty-eight osteopenic women (65–79 years old) were randomly assigned into one of three treatment groups for 6 months: (1) 50 g of dried plum; (2) 100 g of dried plum; and (3) control. Total body, hip, and lumbar bone mineral density (BMD) were evaluated at baseline and 6 months using dual-energy X-ray absorptiometry. Blood biomarkers including bone-specific alkaline phosphatase (BAP), tartrate-resistant acid phosphatase (TRAP-5b), high-sensitivity C-reactive protein (hs-CRP), insulin-like growth factor-1 (IGF-1), and sclerostin were measured at baseline, 3 months, and 6 months. Osteoprotegerin (OPG), receptor activator of nuclear factor kappa-B ligand (RANKL), calcium, phosphorous, and vitamin D were measured at baseline and 6 months.


Both doses of dried plum were able to prevent the loss of total body BMD compared with that of the control group (P < 0.05). TRAP-5b, a marker of bone resorption, decreased at 3 months and this was sustained at 6 months in both 50 and 100 g dried plum groups (P < 0.01 and P < 0.04, respectively). Although there were no significant changes in BAP for either of the dried plum groups, the BAP/TRAP-5b ratio was significantly (P < 0.05) greater at 6 months in both dried plum groups whereas there were no changes in the control group.


These results confirm the ability of dried plum to prevent the loss of total body BMD in older osteopenic postmenopausal women and suggest that a lower dose of dried plum (i.e., 50 g) may be as effective as 100 g of dried plum in preventing bone loss in older, osteopenic postmenopausal women. This may be due, in part, to the ability of dried plums to inhibit bone resorption. This clinical trial was registered at NCT02325895.


Bone turnover biomarkers Estrogen Osteopenia Osteoporosis Prune 



Bone mineral density


Tartrate-resistant acid phosphatase-5b


Bone-specific alkaline phosphatase

25-OH vitamin D

25-hydroxy vitamin D


Insulin-like growth factor-1


High-sensitivity C-reactive protein


Receptor activator of nuclear factor kappa-B ligand




Sclerosteosis gene


C-reactive protein


Procollagen type 1N-terminal propeptide


Collagen type 1 C-telopeptide



We gratefully acknowledge the valuable assistance of the following students at San Diego State University: Mariana Beleche, Sofie Blicher, Jayme Brisco, Bich Thuy Callens, Zachary Clayton, Amanda Cravinho, Jennifer Cullison, Sofia Garcia, Jackie Gaylis, Montserrat Gonzalez, Mairi McLachlan, Tasnim El Mezain, Rose Miller, Ivette Navarro, Dawn Ortiz and, Yenina Vereda. This project was supported by the SDSU Research Foundation grant no. 242409 and a grant from the California Dried Plum Board (grant no. 57114A). The authors thank the California Dried Plum Board for providing us with dried plums and we gratefully acknowledge Nutrisystem, Inc. supplying calcium and vitamin D supplements for the study. The authors’ responsibilities were as follows: SH, MK, and BHA designed the research; SH, DM, and PS conducted the research; SH, MK, and SCC analyzed data; MEP performed statistical analysis; SH, DM, PS, SAJ, and BH wrote the paper; MK, SAJ, and BHA had substantial involvement in manuscript revision before submission; SH had primary responsibility for final content. All authors edited and approved the final version. Shirin Hooshmand, Dina Metti, Pouneh Shamloufard, Mark Kern, Bahram H. Arjmandi, Sheau C. Chai, Sarah A. Johnson, and Mark E. Payton declared that they had no conflict of interest.

Compliance with ethical standards

The Institutional Review Board at San Diego State University approved all procedures involving human subjects. Written informed consent was obtained from all subjects.

Conflicts of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    Colón-Emeric CS, Saag KG (2006) Osteoporotic fractures in older adults. Best Pract Res Clin Rheumatol 20(4):695–706CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Looker AC, Melton LJ, Harris TB, Borrud LG, Shepherd JA (2010) Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J Bone Miner Res 25(1):64–71CrossRefPubMedGoogle Scholar
  3. 3.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–75CrossRefPubMedGoogle Scholar
  4. 4.
    Sambrook PN, Chen JS, Simpson JM, March LM (2010) Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust 193(3):154–6PubMedGoogle Scholar
  5. 5.
    Reid IR (2015) Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol 11(7):418–28CrossRefPubMedGoogle Scholar
  6. 6.
    Cúneo F, Costa-Paiva L, Pinto-Neto AM, Morais SS, Amaya-Farfan J (2010) Effect of dietary supplementation with collagen hydrolysates on bone metabolism of postmenopausal women with low mineral density. Maturitas 65(3):253–7CrossRefPubMedGoogle Scholar
  7. 7.
    Moyer VA (2013) Vitamin D and calcium supplementation to prevent fractures in adults: US preventive services task force recommendation statement. Ann Intern Med 158(9):691–696PubMedGoogle Scholar
  8. 8.
    Ferrari CK (2007) Functional foods and physical activities in health promotion of aging people. Maturitas 58(4):327–39CrossRefPubMedGoogle Scholar
  9. 9.
    Deyhim F, Stoecker BJ, Brusewitz GH, Devareddy L, Arjmandi BH (2005) Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause 12(6):755–62CrossRefPubMedGoogle Scholar
  10. 10.
    Arjmandi BH, Lucas EA, Juma S, Soliman A, Stoecker BJ, Khalil DA, Smith BJ, Wang C (2001) Dried plums prevent ovariectomy-induced bone loss in rats. JANA 4(1):50–6Google Scholar
  11. 11.
    Bu SY, Lucas EA, Franklin M, Marlow D, Brackett DJ, Boldrin EA, Devareddy L, Arjmandi BH, Smith BJ (2007) Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int 18(7):931–42CrossRefPubMedGoogle Scholar
  12. 12.
    Franklin M et al (2006) Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone 39(6):1331–42CrossRefPubMedGoogle Scholar
  13. 13.
    Arjmandi BH, Khalil DA, Lucas EA, Georgis A, Stoecker BJ, Hardin C, Payton ME, Wild RA (2002) Dried plums improve indices of bone formation in postmenopausal women. J Womens Health Gend Based Med 11(1):61–68CrossRefPubMedGoogle Scholar
  14. 14.
    Hooshmand S, Chai SC, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH (2011) Comparative effects of dried plum and dried apple on bone in postmenopausal women. Br J Nutr 106(06):923–930CrossRefPubMedGoogle Scholar
  15. 15.
    Mühlbauer RC, Lozano A, Reinli A, Wetli H (2003) Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 133(11):3592–3597PubMedGoogle Scholar
  16. 16.
    Vinson JA J, Zubik L, Bose P, Samman N, Proch J (2005) Dried fruits: excellent in vitro and in vivo antioxidants. Am Coll Nutr 24(1):44–50CrossRefGoogle Scholar
  17. 17.
    Rendina E, Hembree KD, Davis MK, Marlow D, Clarke SL, Halloran BP, Lucas EA, Smith BJ (2013) Dried plum’s unique capacity to reverse bone loss and alter bone metabolism in postmenopausal osteoporosis model. PLoS One 8(3):e60569CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hooshmand S, Kumar A, Zhang JY, Johnson SA, Chai SC, Arjmandi BH (2015) Evidence for anti-inflammatory and antioxidative properties of dried plum polyphenols in macrophage RAW 264.7 cells. Food Funct 6(5):1719–25CrossRefPubMedGoogle Scholar
  19. 19.
    Bu SY, Hunt TS, Smith BJ (2009) Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I. J Nutr Biochem 20(1):35–44CrossRefPubMedGoogle Scholar
  20. 20.
    Rendina E, Lim YF, Marlow D, Wang Y, Clarke SL, Kuvibidila S, Lucas EA, Smith BJ (2012) Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immune response in C57BL/6J mice. J Nutr Biochem 23(1):60–8CrossRefPubMedGoogle Scholar
  21. 21.
    Hooshmand S, Brisco JR, Arjmandi BH (2014) The effect of dried plum on serum levels of receptor activator of NF-kappaB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. Br J Nutr 112(1):55–60CrossRefPubMedGoogle Scholar
  22. 22.
    Szulc P, Bauer DC, Eastell R (2013) Biochemical markers of bone turnover in osteoporosis, in primer on the metabolic bone diseases and disorders of mineral metabolism. John Wiley & Sons, Inc, pp 297–306CrossRefGoogle Scholar
  23. 23.
    Bolarin D (1996) Biochemical markers for the assessment of skeletal growth in children. Nig Quart J Hosp Med 6:256–261Google Scholar
  24. 24.
    Gundberg C, Looker AC, Nieman SD, Calvo MS (2002) Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 31(6):703–708CrossRefPubMedGoogle Scholar
  25. 25.
    Simonavice E, Liu PY, Ilich JZ, Kim JS, Arjmandi BH, Panton LB (2014) The effects of a 6-month resistance training and dried plum consumption intervention on strength, body composition, blood markers of bone turnover, and inflammation in breast cancer survivors. Appl Physiol Nutr Metab 39(6):730CrossRefPubMedGoogle Scholar
  26. 26.
    Seeman E, Nguyen TV (2015) Bone remodeling markers: so easy to measure, so difficult to interpret. Osteoporos Int.Google Scholar
  27. 27.
    Mubarak A, Swinny EE, Ching SY, Jacob SR, Lacey K, Hodgson JM, Croft KD, Considine MJ (2012) Polyphenol composition of plum selections in relation to total antioxidant capacity. J Agric Food Chem 60(41):10256–62CrossRefPubMedGoogle Scholar
  28. 28.
    Hooshmand S, Arjmandi BH (2009) Viewpoint: dried plum, an emerging functional food that may effectively improve bone health. Ageing Res Rev 8(2):122–127CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2016

Authors and Affiliations

  • S. Hooshmand
    • 1
    Email author
  • M. Kern
    • 1
  • D. Metti
    • 1
  • P. Shamloufard
    • 1
  • S. C. Chai
    • 2
  • S. A. Johnson
    • 3
    • 4
  • M. E. Payton
    • 5
  • B. H. Arjmandi
    • 3
    • 6
  1. 1.School of Exercise and Nutritional SciencesSan Diego State UniversitySan DiegoUSA
  2. 2.Department of Behavioral Health and NutritionUniversity of DelawareNewarkUSA
  3. 3.Center for Advancing Exercise and Nutrition Research on AgingFlorida State UniversityTallahasseeUSA
  4. 4.Department of Food Science and Human NutritionColorado State UniversityFort CollinsUSA
  5. 5.Department of StatisticsOklahoma State UniversityStillwaterUSA
  6. 6.Department of Nutrition, Food and Exercise SciencesFlorida State UniversityTallahasseeUSA

Personalised recommendations